Shan-shan Song

发表

Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance

Yi Chen, Z. Miao, Jian Ding, 2023, EMBO molecular medicine.

Catalyst-free synthesis of benzofuran-fused pyrido[4,3-d]pyrimidines from 2-(2-hydroxyaryl)acetonitrile and 4,6-dichloropyrimidine-5-carbaldehyde through domino condensation reactions

Z. Miao, Chunhao Yang, Zhizhou Yue, 2014 .

Rapid access to α-carbolines via a one-pot tandem reaction of α,β-unsaturated ketones with 2-nitrophenylacetonitrile and the anti-proliferative activities of the products.

Z. Miao, Xiaofei Zhang, Chunhao Yang, 2014, Organic & biomolecular chemistry.

Structure-based optimization of a series of selective BET inhibitors containing aniline or indoline groups.

Z. Miao, Jian Li, B. Xiong, 2018, European journal of medicinal chemistry.

Discovery of a series of dihydroquinoxalin-2(1H)-ones as selective BET inhibitors from a dual PLK1-BRD4 inhibitor.

Z. Miao, B. Xiong, Jing-kang Shen, 2017, European journal of medicinal chemistry.

Glycogen synthase kinase 3β inhibition synergizes with PARP inhibitors through the induction of homologous recombination deficiency in colorectal cancer

Z. Miao, Yu-Nan Tian, Hua-Dong Chen, 2021, Cell Death & Disease.

GSK3β Inhibition Synergizes with PARP Inhibitors through the Induction of Homologous Recombination Deficiency in Colorectal Cancer

Yu-Nan Tian, Miao Zehong, Ao Zhang, 2020 .

SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy

Z. Miao, Shan-shan Song, Xubin Bao, 2022, Neoplasia.

Novel mutations in BRCA2 intron 11 and overexpression of COX-2 and BIRC3 mediate cellular resistance to PARP inhibitors.

Z. Miao, Hua-Dong Chen, Jin-Xue He, 2020, American journal of cancer research.

Development of Potent NEDD8-Activating Enzyme Inhibitors Bearing a Pyrimidotriazole Scaffold.

Z. Miao, Huaqian Ding, Ao Zhang, 2021, Journal of medicinal chemistry.

A new BET inhibitor, 171, inhibits tumor growth through cell proliferation inhibition more than apoptosis induction

Z. Miao, B. Xiong, Jing-kang Shen, 2019, Investigational New Drugs.

Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone.

Z. Miao, L. Jia, Shan-shan Song, 2022, European journal of medicinal chemistry.

Tanshinone-1 induces tumor cell killing, enhanced by inhibition of secondary activation of signaling networks

Y. Chen, Z. Miao, Jian Ding, 2013, Cell Death and Disease.